On September 18, 2025, the Governments of the United States and the United Kingdom signed a Memorandum of Understanding Between the Government of the United States of America and the Government of the United Kingdom of Great Britain and Northern Ireland Regarding the Technology Prosperity Deal. This MOU reflects both countries’ commitment to partnering on critical emerging technologies like AI, quantum, fusion, and civil nuclear to strengthen democratic values, global competitiveness, and shared responses to health, climate, and infrastructure challenges. The overarching goal is to “usher in the next Golden Age of Innovation to fortify freedom and prosperity for generations to come.”
What the Technology Prosperity Deal Encompasses
This MOU lays out a collaborative framework between the U.S. and U.K., intended to expand cooperation across several strategic science and technology disciplines. Key areas of cooperation include:
- Accelerating AI innovation. This includes enabling access to compute, creating shared datasets, and launching joint flagship research programs such as those between U.S. science agencies like the Department of Energy (DOE), National Science Foundation (NSF), and National Institutes of Health (NIH), and their U.K. counterparts (DSIT, UKRI). Priority sub-areas involve AI for biotechnology and precision medicine, fusion energy, space applications including lunar and Martian missions, new AI hardware, and improving AI standards and model evaluations.
- Unleashing civil nuclear energy. This collaboration covers advanced nuclear reactors, advanced fuels, and fusion energy. It also prioritizes streamlining regulations, ensuring supply chain resilience including independence from Russian nuclear fuels by the end of 2028, and promoting exports and deployment of civil nuclear technologies.
- Securing quantum advantage. Planned activities include benchmarking of quantum hardware, software, and algorithms, launching a “Quantum Code Challenge,” advancing quantum sensing and networking, and promoting standards. Applications in finance, health, and energy are prioritized, along with creating industry exchange programs between the U.S. and U.K.
- Foundations for frontier innovation. This includes research security, secure telecommunications, critical infrastructure, cooperation on standards such as 6G, timing and navigation systems, and mobilizing private investment in advanced technologies.
The MOU builds on the earlier U.S.–U.K. Economic Prosperity Deal and clarifies the operational modalities. It specifies how modifications or discontinuations may occur and emphasizes that it is non-binding, meaning no legal obligations or automatic funding commitments. Cooperation must comply with existing laws and international obligations.
Key Dates and Timeline
The MOU includes several important schedule commitments:
- Within six months of when the MOU becomes operative: the U.S. and U.K. will establish and convene a Ministerial-Level Working Group. This group will serve as a strategic forum to set priorities, guide bilateral cooperation, and oversee joint initiatives.
- Within twelve months, and every year thereafter, formal annual discussions between the Parties to assess progress and determine the scope and direction of the next phase of collaborative programs. These meetings will account for emerging opportunities, policy developments, and shared strategic interests.
These are the two explicitly bound deadlines. Other deliverables are ongoing or contingent, such as achieving progress in the underlying Economic Prosperity Deal for this MOU to become operative.
Why This Matters for Human Health and Call to Action
Many of the collaboration areas directly impact human health. AI for biotechnology and precision medicine could accelerate disease diagnosis, treatment plans, and drug discovery, including for cancer, rare, and chronic diseases. Quantum sensing and computing can enable new tools for biomedical research. Ensuring robust supply chains in nuclear and advanced technologies can help with safe energy access, which in turn affects public health through clean air, stable electricity, and climate resilience.
For researchers, companies, and policymakers who are poised to contribute or benefit from such joint U.S.–U.K. efforts, this is a moment to engage. Aligning with the priorities in AI health applications, nuclear safety and fuels, quantum applications for biosensing, or regulatory streamlining are likely to be advantageous.
If your company has considered applying for federal funding, your federal funding journey starts here. EverGlade Consulting is a national firm that helps organizations win and manage federal awards. We offer services ranging from Pursuit, Proposal and Post-Award support to comply with federal regulations at agencies including BARDA, ARPA-H, NIH, DTRA, JPEO, DOD, DIU, DOE, and DARPA.
